T2DM is characterized by two major defects: a dysregulation of pancreatic hormone secretion (quantitative and qualitative – early phase, pulsatility – decrease of insulin secretion, increase in glucagon secretion), and a decrease of insulin action on target tissues (IR) (9). Here, INS is linked to type 2 diabetes mellitus.